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Cytomegalovirus Load
in Bronchoalveolar Lavage
Fluid: A Clue to the Diagnosis
of Cytomegalovirus
Pneumonia?
To the Editor—We read with interest the
article by Westall et al. [1], recently pub-
lished in the Journal of Infectious Diseases,
addressing the issue of human cytomeg-
alovirus (HCMV) load in lung transplant
recipients (LTRs) with or without HCMV
pneumonia. Although these authors add
a substantial amount of data to the few
published studies that include histopath-
ological documentation of HCMV pneu-
monia [2, 3], we feel that some clarifica-
tions are necessary.
As shown by Westall et al., the contri-
bution of qualitative polymerase chain re-
action, be it on bronchoalveolar lavage
(BAL) or plasma samples, to the diagnosis
of HCMV pneumonia is limited by the
less-than-perfect specificity of positive re-
sults for the presence of pneumonia in this
patient population. In addition, the re-
ported series included 2 patients with
plasma samples that were negative at the
time of pneumonia, suggesting that a neg-
ative plasma sample cannot be used to
exclude HCMV pneumonia. This is con-
sistent with our own unpublished obser-
vations. We are interested to know whether
the quantitation of HCMV load in respi-
ratory samples can provide more infor-
mation as to the presence of HCMV pneu-
monia. However, the way Westall et al.
arrived at their HCMV load threshold of
46,000 copies/mL is unclear. We concur
that “intuitively, higher virus loads are more
likely to be associated with more-severe
HCMV disease in LTRs” (p. 1081) and that
a threshold above which the likelihood of
HCMV pneumonia is high might possibly
be defined. This threshold should be set
somewhere between the HCMV loads found
in patients with and without HCMV
pneumonia—for example, “a virus load
2 SD above the mean virus load of all
those LTRs without histological evidence
of HCMV infection” (p. 1081). However,
as stated by the authors in the subsection
entitled “HCMV DNAemia in BAL and
plasma samples: histologically proven
HCMV infection,” the mean HCMV load
in the BAL samples from those LTRs in
whom HCMV pneumonia was not de-
tected histologically (and not, as written
by the authors, “from those LTRs in
whom HCMV DNA was not detected”
[p. 1079], an apparent typographical er-
ror) was copies/mL, which5873 1543
should point to a threshold of ∼9000
copies/mL. This is substantially different
from the 46,000 copies/mL computed by
the authors. Setting a threshold of 46,000
copies/mL appears, therefore, to be both
inconsistent with the proposed method (i.e.,
different from the choice of an HCMV load
2 SD above the mean) and illogical (i.e.,
higher than the HCMV load of 19,460
4917 copies/mL observed in patients
with proven HCMV pneumonia). Per-
haps a convenient way to clarify this
point would be to explicitly demonstrate,
in Westall et al.’s figure 3, which thresh-
olds correspond to the different points of
the receiver operating characteristic curve,
since the best threshold appears obvious
on the basis of the curve shape.
Clarifying these points is important,
since other authors have presented evi-
dence similar to that of Westall et al.—
namely, evidence that a substantial overlap
does exist in the BAL HCMV loads in pa-
tients with and without HCMV pneumo-
nia [2–4]. Whether this diagnostic prob-
lem could be resolved by expressing the
relationship between HCMV load and
the probability of HCMV pneumonia as
a sigmoid curve for HCMV load varying
from 10,000 to 30,000 copies/mL rather
than as a dichotomous relationship, as
shown by Riise et al. [3], or by estimating
HCMV load in the epithelial lining fluid
(as computed using urea dilution) with
a cutoff of ∼10,000 copies/mL, similarly
to Zedtwitz-Liebenstein et al. [4], is yet
unclear to us. We hope this letter will
provide Westall et al. with an opportunity
to clarify these points in their interesting
article.
Pascal R. A. Meylan and Giorgio Zanetti
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Reply to Meylan and Zanetti
To the Editor—We thank Meylan and Za-
netti [1] for their positive review of our
article [2] and are encouraged to see that
